Risk of arterial and venous occlusive events in chronic myeloid leukemia patients treated with new generation BCR-ABL tyrosine kinase inhibitors: a systematic review and meta-analysis

enthalten in: Expert opinion on drug safety | 2017

von Haguet, H. | Douxfils, J. | Mullier, F. | +3

Risk of arterial and venous occlusive events in chronic myeloid leukemia patients treated with new generation BCR-ABL tyrosine kinase inhibitors: A systematic review and meta-analysis

enthalten in: Expert opinion on drug safety | 2016

von Haguet, H. | Douxfils, J. | Mullier, F. | +3